List of Excipients in API lovastatin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lovastatin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | ACETYLTRIBUTYL CITRATE | |
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | BUTYLATED HYDROXYANISOLE | |
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | CANDELILLA WAX | |
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | CELLULOSE ACETATE | |
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | FD&C YELLOW NO. 6 | |
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | FERRIC OXIDE RED | |
| Covis Pharma US Inc | ALTOPREV | lovastatin | 70515-628 | FERROSOFERRIC OXIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing lovastatin
Detailed excipient profiles for lovastatin
Excipient focus: ACETYLTRIBUTYL CITRATE
lovastatin drug variants containing ACETYLTRIBUTYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing ACETYLTRIBUTYL CITRATE
Excipient focus: ANHYDROUS LACTOSE
lovastatin drug variants containing ANHYDROUS LACTOSE
lovastatin drug variants not containing ANHYDROUS LACTOSE
Excipient focus: BUTYLATED HYDROXYANISOLE
lovastatin drug variants containing BUTYLATED HYDROXYANISOLE
lovastatin drug variants not containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CANDELILLA WAX
lovastatin drug variants containing CANDELILLA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing CANDELILLA WAX
Excipient focus: CELLULOSE ACETATE
lovastatin drug variants containing CELLULOSE ACETATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing CELLULOSE ACETATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lovastatin drug variants containing CELLULOSE, MICROCRYSTALLINE
lovastatin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: CI 42090
lovastatin drug variants containing CI 42090
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lovastatin | 50090-3216 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing CI 42090
Excipient focus: D&C RED NO. 30
lovastatin drug variants containing D&C RED NO. 30
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | lovastatin | 0615-7679 |
| Blenheim Pharmacal Inc | lovastatin | 10544-246 |
| McKesson Corporation | lovastatin | 63739-281 |
| Preferred Pharmaceuticals Inc | lovastatin | 68788-9181 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing D&C RED NO. 30
Excipient focus: D&C YELLOW NO. 10
lovastatin drug variants containing D&C YELLOW NO. 10
lovastatin drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
lovastatin drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| NuCare PharmaceuticalsInc | lovastatin | 68071-2653 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1
lovastatin drug variants containing FD&C BLUE NO. 1
lovastatin drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
lovastatin drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| RPK Pharmaceuticals Inc | lovastatin | 53002-5701 |
| NuCare PharmaceuticalsInc | lovastatin | 68071-2653 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
lovastatin drug variants containing FD&C BLUE NO. 2
lovastatin drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
lovastatin drug variants containing FD&C YELLOW NO. 6
lovastatin drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
lovastatin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Eon Labs Inc | lovastatin | 0185-0070 |
| Aphena Pharma Solutions - Tennessee LLC | lovastatin | 67544-245 |
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
lovastatin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Eon Labs Inc | lovastatin | 0185-0070 |
| Aphena Pharma Solutions - Tennessee LLC | lovastatin | 67544-245 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
lovastatin drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERYL MONOSTEARATE
lovastatin drug variants containing GLYCERYL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYPROMELLOSE
lovastatin drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE PHTHALATE
lovastatin drug variants containing HYPROMELLOSE PHTHALATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing HYPROMELLOSE PHTHALATE
Excipient focus: KI203
lovastatin drug variants containing KI203
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lovastatin | 50090-3216 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing KI203
Excipient focus: KI5
lovastatin drug variants containing KI5
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | lovastatin | 50090-3216 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing KI5
Excipient focus: LACTOSE
lovastatin drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
lovastatin drug variants containing LACTOSE MONOHYDRATE
lovastatin drug variants not containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lovastatin drug variants containing MAGNESIUM STEARATE
lovastatin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
lovastatin drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: POLOXAMER 188
lovastatin drug variants containing POLOXAMER 188
lovastatin drug variants not containing POLOXAMER 188
Excipient focus: POLYETHYLENE GLYCOL
lovastatin drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 400
lovastatin drug variants containing POLYETHYLENE GLYCOL 400
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
lovastatin drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
lovastatin drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing POLYSORBATE 80
Excipient focus: PROPYLENE GLYCOL
lovastatin drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing PROPYLENE GLYCOL
Excipient focus: SILICON DIOXIDE
lovastatin drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
lovastatin drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM LAURYL SULFATE
lovastatin drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
lovastatin drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
lovastatin drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
lovastatin drug variants containing STARCH, CORN
lovastatin drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
lovastatin drug variants containing STARCH, PREGELATINIZED CORN
lovastatin drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: SUCROSE
lovastatin drug variants containing SUCROSE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing SUCROSE
Excipient focus: TALC
lovastatin drug variants containing TALC
lovastatin drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
lovastatin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
lovastatin drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Covis Pharma US Inc | lovastatin | 70515-628 |
| >Company | >Ingredient | >NDC |
lovastatin drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links